Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Oncology
Sort By
Newest First
1 / 21
Immuno-oncology
Immuno-Oncology at the Forefront of Cancer Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-10
Mar 02, 2025
Oncology
From Coley’s Toxins to mRNA: Reflecting on the History of Cancer Vaccines
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-03
Mar 02, 2025
Small Biotechs
Five Small Biotechs to Watch: March 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-06
Feb 28, 2025
Radioconjugates
Rising Interest in Radioconjugate Therapies
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-02-25-NI-05
Feb 25, 2025
Biotechs
Five Small Biotechs to Watch: February 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-01
Feb 03, 2025
oncology
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
SOPHiA Genetics
PR-11-24-NI-120
Nov 21, 2024
Novel Nucleoside
Transposon Therapeutics Acquired a Portfolio of Novel Nucleoside Analogs for Oncology To Enhance Development Pipeline
Transposon Therapeutics
PR-11-24-NI-119
Nov 21, 2024
Chemotherapy
Modernizing Dated Approaches to Oncology Care
FivepHusion
PAO-11-24-RTM-01
Nov 06, 2024
Biosensors
The Partnerships Powering Next-Gen Oncology Care
Olivia Newton-John Cancer Research Institute
PAO-10-24-RTM-10
Nov 06, 2024
Oncology
Celebrating a Decade of Oncology Innovation at ONJ
Olivia Newton-John Cancer Research Institute
PAO-10-24-RTM-08
Nov 05, 2024
Melanoma
Understanding the Challenges in Tackling Melanoma and Other Forms of Cancer
Olivia Newton-John Cancer Research Institute
PAO-10-24-RTM-07
Nov 05, 2024
Oncology
Up Close and Personal with Scientists on the Cutting Edge of Melanoma Research
Olivia Newton-John Cancer Research Institute
PAO-10-24-RTM-06
Nov 05, 2024
Oncology Trials
Navigating the Complex Landscape of Oncology Trials
Colin Hayward, MB BS
Ergomed
PAO-10-24-CL-04
Oct 22, 2024
Bioassays
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Anke Hartung, Ph.D.,
Tanvex CDMO
PAO-09-24-CL-09
Sep 30, 2024
Chronic Diseases
Transforming the Management of Chronic Diseases with Biosimilars
Hugo Sotelo; Jorge Catella
Biosidus
PAO-07-24-CL-10
Jul 16, 2024
Protein Degradation
PROTACS: Upgrading Small Molecule Inhibitors
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-24-NI-02
Jun 11, 2024
Clinical Trials
Optimizing Oncology and Rare Disease Clinical Trials by Focusing on Science and Aligning with both Patients and Investigators
Dave Selkirk
Ergomed
PAO-06-24-CL-09
May 30, 2024
FDA Approval
Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol
Lamassu Biotech
PR-M04-24-01
Apr 19, 2024
Clinical Trial Enrollment
NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
NMDP
PR-M03-24-01
Mar 05, 2024
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07
Nov 09, 2023
1 / 21
